Trial intelligence / Profile preview

Comparison of Three Different Anesthetic Methods in ECT

NCT07824817Phase 4Recruiting

Sponsor
Inonu University
Start
Sep 2026
Primary completion
Feb 2027
Countries
1
01

Overview

A Phase 4 trial of dexmedetomidine, remifentanil in hemodynamic response, sponsored by Inonu University. Started Sep 2026; status: recruiting.

02

Drugs

dexmedetomidineremifentanil
03

Conditions

hemodynamic response

Beyond the preview

Go deeper on NCT07824817.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07824817.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call